Orsini, a leader in rare disease pharmacy solutions, announced a new partnership with Dos Rx, a global leader in international medical travel facilitation for patients receiving complex care while in the U.S. As a partner to Dos Rx, Orsini will dispense specialty therapies to medical travelers as part of their holistic treatments in the U.S. with no interruption to prescribed therapies.
Health Technology Insights: Zydus, RK Pharma Sign US Oncology Support Deal
Dos Rx delivers fully integrated pharmacy services and orchestrates pharmacy logistics to streamline medication access for international patients.
Health Technology Insights: Novo Nordisk Files for FDA Approval of a Higher Dose of Wegovy Injection 7.2 MG
“International patients face enough complexity in their care journey. Pharmacy shouldn’t add to it. Orsini’s deep expertise in rare disease therapies complements our mission to remove friction from the international medical travel experience. Together, we’re ensuring that every patient can access the life-changing medications they need while receiving care in the U.S.,” said Tim Whitaker, Founder and CEO of Dos Rx.
Orsini’s partnership with Dos Rx will allow travelers in the U.S. with rare diseases to access seamless, cost-effective, and language-inclusive pharmaceutical care more easily and quickly.
“Orsini’s mission is to ensure that no patient is left behind, and with Dos Rx we can expand those efforts to include more patients than ever before,” Brandon Tom, Orsini’s Chief Executive Officer, said. “Our patient-first care model and Dos Rx’s ability to navigate logistical challenges are powerful tools, which will combine to ensure rare disease patients traveling to the U.S. receive the care they need.”
Health Technology Insights: Chris Cleary Named Chairman at Restore Medical
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
Source- PR Newswire
